Home    Investing

LATEST Equities  

Biotech investors zero in on gene therapy as next big frontier

Fund managers have bullish outlook for gene-editing technology in long run.

How global fund managers view SA investment opportunities

Where a company is domiciled matters less than fundamentals.

Animal healthcare – an opportunity for investors

People see pets as part of the family.

Can the JSE sustain momentum ahead of elections?

Headwinds to equity market performance in SA 'largely dependent' on election period, says Fatima Vawda, MD of 27four Investment Managers.

Where are mid caps headed?

Is the recovery underway?

Cash vs equity returns: is the last five years unusual?

Local cash has outperformed equities over five years, leaving investors to wonder if something has changed.

From base zero and still growing

From a team of two, financial services group Mergence believes that with 86 staff, it is just hitting its stride.

How do I start a share portfolio?

What is a good balanced portfolio to start with for someone in their 20s?

Fund managers turn bullish on EM equities

BofA Merril Lynch survey shows market is at its most undervalued since October 2011.

Can you spot the next JSE superhero?

Are there lessons for investors?

JSE Superhero No 3 – Naspers

Superpower: Trendspotting.

JSE Superhero No 2 – Capitec

Superpower: Flexibility.

More diversification with Section 12J

Westbrooke expands its February 2019 investment offerings.

JSE Superhero No 1 – Clicks

Superpower: Reliability.

Podcasts

GO TO SHOP CART

Follow us:

Search Articles:Advanced Search
Click a Company:
server: 172.17.0.2